Back to Trades
Total Value
$124.1K
Net $124.1K sold
Filing Date
Mar 19, 2026
1 transaction
Sales
$124.1K
1 transaction
Trade Summary
On Mar 17, 2026, Ogden Christopher, Insider, sold $124.1K of CytomX Therapeutics, Inc. (CTMX) across 1 transaction. The filing covers Common Stock and reflects net selling of $124.1K. Reported prices ranged from $6.42. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- CytomX Therapeutics, Inc.
- Ticker Symbol
- CTMX
- CIK
- 0001501989
Insider Information
- Role
- Insider
- Location
- SOUTH SAN FRANCISCO, CA
Filing Details
- Filing Date
- Mar 19, 2026
- Transaction Date
- Mar 17, 2026
- Accession Number
- 0001610717-26-000122
- Form Type
- 4
- Net Trading Amount
- -$124.1K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock | 19,323 | $6.42 | Sale | $124.1K |
Want live alerts when Ogden Christopher trades again?
Download Insider Trades to track CTMX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- (F2)Includes 173,082 RSUs.